Microsoft's AI for Good Lab Backs Cancer Research

- The grant provides a combined $2 million, with $1 million in research funding from the consortium and another $1 million in computing support from Microsoft's AI for Good Lab. - The research will specifically target high-grade serous ovarian cancer (HGSOC), which is the most common and deadliest form of the disease. - An international team of researchers from the United States, United Kingdom, Canada, and Australia will lead the project. - The project's goal is to analyze one of the largest-ever assembled international collections of ovarian cancer data, including tumor samples, genetics, and lifestyle factors, to better predict patient survival and response to treatment. - This inaugural "AI Accelerator Grant" was a highly competitive process, attracting 21 applications from research teams around the world. - The Global Ovarian Cancer Research Consortium was formed in 2024 by uniting four leading research organizations from the US, UK, Canada, and Australia to overcome research stalls in a disease that has seen limited improvement in survival rates for decades. - The AI models will be used to identify complex patterns in the data that are not detectable with current tools, aiming to create new tools for clinicians to personalize patient care. - Microsoft's Chief Data Scientist and Director of its AI for Good Lab, Juan Lavista Ferres, noted that pairing deep scientific expertise with advanced AI is key to accelerating urgently needed discoveries.